CCL2 and breast cancer: Gu et al. demonstrated that BC cell-derived exosomes containing miR-200b-3p activate the AKT/NF-κB p65 signaling pathway by inhibiting PTEN expression, thereby promoting the expression of CC motif chemokine ligand 2 (CCL2).